An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 14, 2015

Primary Completion Date

September 6, 2016

Study Completion Date

August 8, 2017

Conditions
Colitis, Ulcerative
Interventions
DRUG

GED-0301

Trial Locations (36)

1632

Multiprofile Hospital for Active Treatment Doverie AD, Sofia

1712

Multiprofile Hospital for Active Treatment Sveti Panteleimon - Sofia AD, Sofia

3600

Multiprofile Hospotal for Active Treatment- Sveti Nikolay Chudotvoretz - LOM EOOD, Lom

8600

Pandy Kalman Megyei Korhaz, Siófok

10016

Concorde Medical Group, New York

14621

Rochester General Hospital, Rochester

20815

Chevy Chase Clinical Research, Chevy Chase

23249

McGuire Veterans Affairs Medical Center, Richmond

32605

Florida Research Network, LLC, Gainesville

32789

Shafran Gastroenterology Center, Winter Park

33136

University of Miami School of Medicine, Miami

34102

Gastroenterology Group of Naples, Naples

37211

Nashville Gastrointestinal Specialists, Nashville

37212

Vanderbilt University, Nashville

38138

Gastroenterology Center of The Midsouth PC, Germantown

40536

University of Kentucky, Lexington

44106

Case Western Reserve University, Cleveland

53715

Dean Medical Center, Madison

75231

Texas Digestive Disease Consultants - Dallas, Dallas

76092

Texas Digestive Disease Consultants - Southlake, Southlake

77030

Baylor College of Medicine, Houston

82606

Univerzitna nemocnica Bratislava, Bratislava

83104

IBD Centrum s.r.o., Bratislava

92123

Medical Associates Research Associates, San Diego

92660

Macks Research Group, Newport Beach

03756

Dartmouth Hitchcock Medical Center, Lebanon

V6Z 2K5

GI Research Institute, Vancouver

N6A 5A5

London Health Sciences Centre, University Hospital, London

L4L 4Y7

Toronto Digestive Disease Associates Inc, Vaughan

42-200

Centrum Medyczne sw. Lukasza, Częstochowa

81-756

Endoskopia Sp. z o.o., Sopot

00-632

Centrum Zdrowia Matki, Dziecka i Mlodziezy, Warsaw

53-025

LexMedica Osrodek Badan Klinicznych, Wroclaw

975 17

Fakultna nemocnica s poliklinikou F. D. Roosevelta, Banská Bystrica

949 01

KM Management, spol. s r.o., Nitra

080 01

GASTRO I., s.r.o., Prešov

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY

NCT02601300 - An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis | Biotech Hunter | Biotech Hunter